Search Results - "Leimane, V"

European Union Standards for Tuberculosis Care by MIGLIORI, G. B, ZELLWEGER, J. P, KLIIMAN, K, AKSAMIT, T, CIRILLO, D. M, DANILOVITS, M, DARA, M, DHEDA, K, DINH-XUAN, A. T, KLUGE, H, LANGE, C, LEIMANE, V, ABUBAKAR, I, LODDENKEMPER, R, NICOD, L. P, RAVIGLIONE, M. C, SPANEVELLO, A, THOMSEN, V. O, VILLAR, M, WANLIN, M, WEDZICHA, J. A, ZUMLA, A, BLASI, F, IBRAIM, E, HUITRIC, E, SANDGREN, A, MANISSERO, D, CAMINERO, J. A, DE VRIES, G, D'AMBROSIO, L, CENTIS, R, SOTGIU, G, MENEGALE, O

“…The European Centre for Disease Prevention and Control (ECDC) and the European Respiratory Society (ERS) jointly developed European Union Standards for…”
Get full text

Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004 by Leimane, V, Dravniece, G, Riekstina, V, Sture, I, Kammerer, S, Chen, M P, Skenders, G, Holtz, T H

“…In the present study, we characterised drug-resistance patterns, compared treatment outcome between extensively and nonextensively drug-resistant tuberculosis…”
Get full text

Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients by PODEWILS, L. J., HOLTZ, T., RIEKSTINA, V., SKRIPCONOKA, V., ZAROVSKA, E., KIRVELAITE, G., KREIGERE, E., LEIMANE, V.

“…Despite the adoption of strategies to prevent and treat multidrug-resistant tuberculosis (MDR-TB) over the past decade, Latvia continues to have one of the…”
Get full text

Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004 by BLOSS, E, KUKSA, L, HOLTZ, T. H, RIEKSTINA, V, SKRIPCONOKA, V, KAMMERER, S, LEIMANE, V

“…Latvia has one of the highest rates of multidrug-resistant tuberculosis (MDR-TB) globally. Clinical management of MDR-TB requires lengthy multidrug regimens…”
Get full text

Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis by Kurbatova, E. V., Gammino, V. M., Bayona, J., Becerra, M. C., Danilovitz, M., Falzon, D., Gelmanova, I., Keshavjee, S., Leimane, V., Mitnick, C. D., Quelapio, M. I., Riekstina, V., Taylor, A., Viiklepp, P., Zignol, M., Cegielski, J. P.

“…OBJECTIVE: To identify predictors of initial sputum culture conversion, estimate the usefulness of persistent positive cultures at different time points in…”
Get full text

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis by LASERSON, K. F, THORPE, L. E, CEGIELSKI, J. P, GRZEMSKA, M, GUPTA, R, ESPINAL, M, LEIMANE, V, WEYER, K, MITNICK, C. D, RIEKSTINA, V, ZAROVSKA, E, RICH, M. L, FRASER, H. S. F, ALARCON, E

“…SETTING: Globally it is estimated that 273000 new cases of multidrug-resistant tuberculosis (MDR-TB, resistance to isoniazid and rifampicin) occurred in 2000…”
Get full text

Implementation of the INNO-LiPA Rif.TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia by SKENDERS, G, HOLTZ, T. H, RIEKSTINA, V, LEIMANE, V

Get full text

Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis by Dravniece, G, Cain, K. P, Holtz, T. H, Riekstina, V, Leimane, V, Zaleskis, R

“…Extensively drug-resistant (XDR) tuberculosis (TB) poses significant management challenges as there are limited pharmacological treatment options for cure…”
Get full text

Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative by Nathanson, E, Gupta, R, Huamani, P, Leimane, V, Pasechnikov, A D, Tupasi, T E, Vink, K, Jaramillo, E, Espinal, M A

“…Adverse events associated with second-line drugs have been mentioned as obstacles in the management of multidrug-resistant tuberculosis (MDR-TB). Data on…”
Get full text

Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia by Skenders, G K, Holtz, T H, Riekstina, V, Leimane, V

“…SETTING: In Latvia, 11% of tuberculosis (TB) patients have multidrug-resistant TB (MDR-TB). The INNO-LiPA Rif.TB ® line-probe assay (LPA) detects rifampin…”
Get full text

Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes by Leimane, V, Leimans, J

“…From 1991 until the end of 1998, the number of patients with tuberculosis in Latvia increased 2.5 times with a simultaneous increase of drug resistant and…”
Get full text

Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects by GAMMINO, V. M, TAYLOR, A. B, LEIMANE, V, MITNICK, C. D, QUELAPIO, M. I. D, RIEKTSINA, V, TUPASI, T. E, WELLS, C. D, ZIGNOL, M, CEGIELSKI, P. J, RICH, M. L, BAYONA, J, BECERRA, M. C, BONILLA, C, GELMANOVA, I, HOLLO, V, JARAMILLO, E, KESHAVJEE, S

“…BACKGROUND: Multidrug-resistant tuberculosis programs in DOTS-Plus pilot sites in ve countries. OBJECTIVES: To calculate sputum conversion time and its…”
Get full text

Frequency and type of microbiological monitoring of multidrug-resistant tuberculosis treatment by KURBATOVA, E. V, GAMMINO, V. M, QUELAPIO, M. I. D, RIEKSTINA, V, TAYLOR, A, VIIKLEPP, P, ZIGNOL, M, CEGIELSKI, J. P, BAYONA, J, BECERRA, M, DANILOVITZ, M, FALZON, D, GELMANOVA, I, KESHAVJEE, S, LEIMANE, V, MITNICK, C. D

“…Monthly culture is usually recommended to monitor treatment of multidrug-resistant tuberculosis (MDR-TB). As mycobacterial laboratory capacity is limited in…”
Get full text

Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia [Short Communication] by RIEKSTINA, V, LEIMANE, V, HOLTZ, T. H, LEIMANS, J, WELLS, C. D

“…International guidelines for treatment outcome analysis of tuberculosis cases have been published and are widely used. They do not, however, fully address the…”
Get full text

Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia by MOROZOVA, I, RIEKSTINA, V, STURE, G, WELLS, C, LEIMANE, V

“…Latvia, a country with levels of multidrug-resistant (MDR) TB among the highest in the world, experienced a 58-fold increase in HIV seroprevalence among all…”
Get full text

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes by FALZON, Dennis, GANDHI, Neel, D'AMBROSIO, Lia, LANGE, Christoph G, BAUER, Melissa, MENZIES, Dick, MIGLIORI, Giovanni B, SOTGIU, Giovanni, COX, Helen S, HOLTZ, Timothy H, HOLLM-DELGADO, Maria-Graciela, KESHAVJEE, Salmaan, DERIEMER, Kathryn, CENTIS, Rosella

“…A meta-analysis for response to treatment was undertaken using individual data of multidrug-resistant tuberculosis (MDR-TB) (resistance to isoniazid and…”
Get full text

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update by Falzon, D, Jaramillo, E, Schünemann, H J, Arentz, M, Bauer, M, Bayona, J, Blanc, L, Caminero, J A, Daley, C L, Duncombe, C, Fitzpatrick, C, Gebhard, A, Getahun, H, Henkens, M, Holtz, T H, Keravec, J, Keshavjee, S, Khan, A J, Kulier, R, Leimane, V, Lienhardt, C, Lu, C, Mariandyshev, A, Migliori, G B, Mirzayev, F, Mitnick, C D, Nunn, P, Nwagboniwe, G, Oxlade, O, Palmero, D, Pavlinac, P, Quelapio, M I, Raviglione, M C, Rich, M L, Royce, S, Rüsch-Gerdes, S, Salakaia, A, Sarin, R, Sculier, D, Varaine, F, Vitoria, M, Walson, J L, Wares, F, Weyer, K, White, R A, Zignol, M

“…The production of guidelines for the management of drug-resistant tuberculosis (TB) fits the mandate of the World Health Organization (WHO) to support…”
Get full text

Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis by BATTISTA MIGLIORI, Giovanni, SOTGIU, Giovanni, D'AMBROSIO, Lia, SPANEVELLO, Antonio, BAUER, Melissa, CHAN, Edward D, SCHAAF, H. Simon, KESHAVJEE, Salmaan, HOLTZ, Timothy H, MENZIES, Dick, GANDHI, Neel R, FALZON, Dennis, DERIEMER, Kathryn, CENTIS, Rosella, HOLLM-DELGADO, Maria-Graciela, PALMERO, Domingo, PEREZ-GUZMAN, Carlos, VARGAS, Mario H

“…The broadest pattern of tuberculosis (TB) drug resistance for which a consensus definition exists is extensively drug-resistant (XDR)-TB. It is not known if…”
Get full text

Multi- and extensively drug-resistant tuberculosis in Latvia: trends, characteristics and treatment outcomes by Kuksa, L., Riekstina, V., Leimane, V., Ozere, I., Skenders, G., Van den Bergh, R., Kremer, K., Acosta, C. D., Harries, A. D.

“…Setting: Drug-resistant tuberculosis (TB) is an important public health problem in Latvia.Objective: To document trends, characteristics and treatment outcomes…”
Get full text

Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis by Fox, Gregory J., Mitnick, Carole D., Benedetti, Andrea, Chan, Edward D., Becerra, Mercedes, Chiang, Chen-Yuan, Keshavjee, Salmaan, Koh, Won-Jung, Shiraishi, Yuji, Viiklepp, Piret, Yim, Jae-Joon, Pasvol, Geoffrey, Robert, Jerome, Shim, Tae Sun, Shin, Sonya S., Menzies, Dick

“…Background. Medical treatment for multidrug-resistant (MDR)-tuberculosis is complex, toxic, and associated with poor outcomes. Surgical lung resection may be…”
Get full text